Link Between Potassium Channel Function and Location in Brain Cells Could Unlock New Epilepsy Treatments
Osaka, Japan – Potassium KCNQ2/3 channels are crucial for suppressing the excitability of brain cells, or neurons. When these channels don’t work properly, they can cause specific types of epilepsy, including benign familial neonatal convulsions and early infantile epileptic encephalopathy.
Recent research published in the Proceedings of the National Academy of Sciences (PNAS) has revealed the relationship between KCNQ2/3 channel functionality and localization, offering potential implications for treating these epileptic disorders. Source
The Importance of Location and Function
For KCNQ2/3 channels to function correctly in the brain, they must be fully functional and located in the correct cellular region – specifically the axon initial segment (AIS). The AIS is the site in neurons where electrical signals are first triggered, controlling nerve cell activity. This led researchers to investigate whether the functionality of KCNQ2/3 channels affects their cellular localization.
Study Findings: A Direct Link Between Function and Location
The research team genetically engineered the functionality of the channels and then used channel trafficking imaging to visualize their location in the AIS. They demonstrated that KCNQ2/3 functionality is linked to its trafficking to the correct cellular localization. Single-molecule imaging revealed that reduced KCNQ3 functionality reduced the AIS localization of KCNQ2/3 by altering the entire trafficking pathway.
“Because we already knew that the localization of KCNQ2/3 to the AIS is regulated by a protein known as ankyrinG, or ankG, we next decided to explore the interactions between full-length KCNQ3 and ankG,” explains lead author of the study Daisuke Yoshioka. They found that the active conformation of KCNQ3 was essential for its stable binding to ankG, further confirming that functional KCNQ2/3 is needed to ensure its proper accumulation at the AIS.
Implications for Epilepsy Treatment
These findings highlight the mechanisms underlying the link between KCNQ2/3 functionality and localization, and provide clues about how their alterations might affect neuronal excitability.
“Now that we know that KCNQ2/3 functionality is closely linked to its localization at the AIS, we have a more concrete target for studying disorders involving altered KCNQ2/3 channels,” says Yasushi Okamura, senior author of the study. “Keeping these potassium channels functioning properly may also be key for ensuring they reach the proper location in brain cells.”
Given that KCNQ2/3-related neurological disorders, including epilepsy, remain relatively poorly understood and can be hard to treat, these findings have important implications. They may contribute to the development of new therapeutic strategies that improve the quality of life for young patients and their families.
Further research into KCNQ channels and their role in neurological disorders is ongoing. Source, Source, Source